510(k) device
GI Windows Flexagon Plus OTOLoc System
GI Windows Surgical · Magnetic Compression Anastomosis System (SAH, Class II) · First FDA decision Oct 28, 2026, newest Oct 28, 2026Obesity
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
510(k) pathway
Device trials
3
Naming "Windows Flexagon Plus"
MAUDE reports
0
Brand "Windows Flexagon Plus", since 2015
PubMed studies
0
Mentioning "Windows Flexagon Plus"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing GI Windows Flexagon Plus OTOLoc System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology, with pictures of the device
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
K261630 · Decided Oct 28, 2026 · 163 days after receipt
Device type: Magnetic Compression Anastomosis System (SAH) · General & Plastic Surgery
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Windows Flexagon Plus", any status and sponsor, newest update first.
- Flexagon Plus OTOLoc Colon Anastomosis in Patients Undergoing SurgeryActive, not recruiting
GI Windows, Inc.Not on our public-company list
NCT06915818 · 65 participants (planned) · Start Mar 29, 2025 · Primary completion Feb 2027
Device: Ileo-colic and colo-colonic Anastomosis with Flexagon SFM and OTOLoc · For: Colon Anastomosis
Sites: Santiago, Chile; Indore, India
2 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Windows Flexagon Plus", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code SAH
1 reports: 0 malfunction, 1 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Windows Flexagon Plus"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code SAH.
- Self-Forming Magnet (Flexagon Plus OTOLoc)GI Windows, Inc. · 510(k) 2026
- MagDI System (MAG-02, DS-01)Gt Metabolic Solutions, Inc. · De Novo 2025
- GT Metabolic Magnet System (MAG-04Gt Metabolic Solutions, Inc. · 510(k) 2026
- GT Metabolic MagDI System (MAG-01, MAG-02, DS-01)Gt Metabolic Solutions, Inc. · 510(k) 2026
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.